Pharmaceutical Technology serves as the connection to bio manufacturing and development, featuring regulatory updates and ...

Administering Shingrix previously required combining a lyophilised antigen with a liquid adjuvant from two separate vials.

The Institute of Food Technologists (IFT), a nonprofit scientific organization committed to advancing the science of food and its application across the global food system, is proud ...

Built by the Institute of Food Technologists team of food scientists, this platform uses AI to connect users to IFT’s research and published content while they’re developing food and beverage products ...

Intrepid Labs was spun out of the University of Toronto to pioneer the use of artificial intelligence and robotics to redefine drug formulation and accelerate therapeutic development.

Galmed Signed Term Sheet for the Development of Novel Semaglutide Sublingual Formulation Published Apr 28, 2025 8:00am EDT ...

Meet Honeybun and Breeze Through Viscometry in Formulation Development In this webinar, Andre Mueller will introduce you to Honeybun, the viscometer/rheometer that will get you all the viscosity data ...

HUNTSVILLE, AL, April 15, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. ("Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform ™ drug ...

HUNTSVILLE, AL, April 15, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform ™ drug ...

The absence of an immune response to Serina’s POZ-lipid represents a novel discovery that could enable the development of safer and more effective LNP formulations for gene therapy and RNA-based ...

Serina Therapeutics to Present at the 4th LNP Formulation & Process Development Summit Provided by GlobeNewswire Apr 15, 2025, 3:30:00 AM ...

Conduit Pharmaceuticals has established a strategic services agreement with Agility Life Sciences, an award-winning formulation development CDMO, enhancing its capabilities in drug formulation for ...